Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Heterologous recombinant expression of non-originator NISTmAb.

Kashi L, Yandrofski K, Preston RJ, Arbogast LW, Giddens JP, Marino JP, Schiel JE, Kelman Z.

MAbs. 2018 Jun 29. doi: 10.1080/19420862.2018.1486355. [Epub ahead of print]

PMID:
29958062
2.

The role of mass spectrometry in the characterization of biologic protein products.

Rathore D, Faustino A, Schiel J, Pang E, Boyne M, Rogstad S.

Expert Rev Proteomics. 2018 May;15(5):431-449. doi: 10.1080/14789450.2018.1469982. Epub 2018 May 10.

PMID:
29694790
3.

The NISTmAb Reference Material 8671 lifecycle management and quality plan.

Schiel JE, Turner A.

Anal Bioanal Chem. 2018 Mar;410(8):2067-2078. doi: 10.1007/s00216-017-0844-2. Epub 2018 Feb 12.

4.

Development of orthogonal NISTmAb size heterogeneity control methods.

Turner A, Yandrofski K, Telikepalli S, King J, Heckert A, Filliben J, Ripple D, Schiel JE.

Anal Bioanal Chem. 2018 Mar;410(8):2095-2110. doi: 10.1007/s00216-017-0819-3. Epub 2018 Feb 10.

5.

Qualification of NISTmAb charge heterogeneity control assays.

Turner A, Schiel JE.

Anal Bioanal Chem. 2018 Mar;410(8):2079-2093. doi: 10.1007/s00216-017-0816-6. Epub 2018 Feb 9.

6.

Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

Mouchahoir T, Schiel JE.

Anal Bioanal Chem. 2018 Mar;410(8):2111-2126. doi: 10.1007/s00216-018-0848-6. Epub 2018 Feb 7.

7.

The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability.

Schiel JE, Turner A, Mouchahoir T, Yandrofski K, Telikepalli S, King J, DeRose P, Ripple D, Phinney K.

Anal Bioanal Chem. 2018 Mar;410(8):2127-2139. doi: 10.1007/s00216-017-0800-1. Epub 2018 Feb 7.

8.

FYCO1 regulates accumulation of post-mitotic midbodies by mediating LC3-dependent midbody degradation.

Dionne LK, Peterman E, Schiel J, Gibieža P, Skeberdis VA, Jimeno A, Wang XJ, Prekeris R.

J Cell Sci. 2017 Dec 1;130(23):4051-4062. doi: 10.1242/jcs.208983.

9.

Multivariate Analysis of Two-Dimensional 1H, 13C Methyl NMR Spectra of Monoclonal Antibody Therapeutics To Facilitate Assessment of Higher Order Structure.

Arbogast LW, Delaglio F, Schiel JE, Marino JP.

Anal Chem. 2017 Nov 7;89(21):11839-11845. doi: 10.1021/acs.analchem.7b03571. Epub 2017 Oct 14.

PMID:
28937210
10.

Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.

Anderson EM, Haupt A, Schiel JA, Chou E, Machado HB, Strezoska Ž, Lenger S, McClelland S, Birmingham A, Vermeulen A, Smith Av.

J Biotechnol. 2015 Oct 10;211:56-65. doi: 10.1016/j.jbiotec.2015.06.427. Epub 2015 Jul 17.

11.

Comparison of Traditional 2-AB Fluorescence LC-MS/MS and Automated LC-MS for the Comparative Glycan Analysis of Monoclonal Antibodies.

Schiel JE, Rogstad SM, Boyne MT 2nd.

J Pharm Sci. 2015 Aug;104(8):2464-72. doi: 10.1002/jps.24522. Epub 2015 Jun 5.

PMID:
26053232
12.

Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody.

Agarabi CD, Schiel JE, Lute SC, Chavez BK, Boyne MT 2nd, Brorson KA, Khan M, Read EK.

J Pharm Sci. 2015 Jun;104(6):1919-1928. doi: 10.1002/jps.24420. Epub 2015 Mar 11.

PMID:
25762022
13.

Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling.

Ito Y, Correll K, Schiel JA, Finigan JH, Prekeris R, Mason RJ.

Am J Physiol Lung Cell Mol Physiol. 2014 Jul 1;307(1):L94-105. doi: 10.1152/ajplung.00233.2013. Epub 2014 Apr 18.

14.

Universal proteolysis and MS(n) for N- and O-glycan branching analysis.

Schiel JE, Smith NJ, Phinney KW.

J Mass Spectrom. 2013 Apr;48(4):533-8. doi: 10.1002/jms.3196.

PMID:
23584946
15.

Endocytic transport and cytokinesis: from regulation of the cytoskeleton to midbody inheritance.

Schiel JA, Childs C, Prekeris R.

Trends Cell Biol. 2013 Jul;23(7):319-27. doi: 10.1016/j.tcb.2013.02.003. Epub 2013 Mar 20. Review.

16.

Membrane dynamics during cytokinesis.

Schiel JA, Prekeris R.

Curr Opin Cell Biol. 2013 Feb;25(1):92-8. doi: 10.1016/j.ceb.2012.10.012. Epub 2012 Nov 21. Review.

17.

FIP3-endosome-dependent formation of the secondary ingression mediates ESCRT-III recruitment during cytokinesis.

Schiel JA, Simon GC, Zaharris C, Weisz J, Castle D, Wu CC, Prekeris R.

Nat Cell Biol. 2012 Oct;14(10):1068-78. doi: 10.1038/ncb2577. Epub 2012 Sep 23.

18.

Glycoprotein analysis using mass spectrometry: unraveling the layers of complexity.

Schiel JE.

Anal Bioanal Chem. 2012 Sep;404(4):1141-9. doi: 10.1007/s00216-012-6185-2. Epub 2012 Jun 26. Review.

PMID:
22733248
19.

LC-MS/MS biopharmaceutical glycoanalysis: identification of desirable reference material characteristics.

Schiel JE, Au J, He HJ, Phinney KW.

Anal Bioanal Chem. 2012 Jun;403(8):2279-89. doi: 10.1007/s00216-012-5749-5. Epub 2012 Feb 22.

PMID:
22354569
20.

Development of a flow-based ultrafast immunoextraction and reverse displacement immunoassay: analysis of free drug fractions.

Schiel JE, Tong Z, Sakulthaew C, Hage DS.

Anal Chem. 2011 Dec 15;83(24):9384-90. doi: 10.1021/ac201973v. Epub 2011 Nov 28.

21.

ESCRT or endosomes?: Tales of the separation of two daughter cells.

Schiel JA, Prekeris R.

Commun Integr Biol. 2011 Sep;4(5):606-8. doi: 10.4161/cib.4.5.16789. Epub 2011 Sep 1.

22.

A quantitative LC-MS/MS method for comparative analysis of capture-antibody affinity toward protein antigens.

Lowenthal MS, Gasca-Aragon H, Schiel JE, Dodder NG, Bunk DM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 15;879(26):2726-32. doi: 10.1016/j.jchromb.2011.07.037. Epub 2011 Aug 2.

PMID:
21856254
23.

Mass spectrometry characterization for chemoenzymatic glycoprotein synthesis.

Schiel JE, Lowenthal MS, Phinney KW.

J Mass Spectrom. 2011 Jul;46(7):649-57. doi: 10.1002/jms.1934.

PMID:
21706674
24.

Endocytic membrane fusion and buckling-induced microtubule severing mediate cell abscission.

Schiel JA, Park K, Morphew MK, Reid E, Hoenger A, Prekeris R.

J Cell Sci. 2011 May 1;124(Pt 9):1411-24. doi: 10.1242/jcs.081448. Epub 2011 Apr 12.

25.

Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns.

Tong Z, Schiel JE, Papastavros E, Ohnmacht CM, Smith QR, Hage DS.

J Chromatogr A. 2011 Apr 15;1218(15):2065-71. doi: 10.1016/j.chroma.2010.10.070. Epub 2010 Oct 23.

26.

Making the final cut - mechanisms mediating the abscission step of cytokinesis.

Schiel JA, Prekeris R.

ScientificWorldJournal. 2010 Jul 19;10:1424-34. doi: 10.1100/tsw.2010.129. Review.

27.

Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding.

Yoo MJ, Schiel JE, Hage DS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 15;878(20):1707-13. doi: 10.1016/j.jchromb.2010.04.028. Epub 2010 Apr 24.

28.

Biointeraction affinity chromatography: general principles and recent developments.

Schiel JE, Joseph KS, Hage DS.

Adv Chromatogr. 2010;48:145-93. Review. No abstract available.

PMID:
20166555
29.

Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography.

Chen J, Schiel JE, Hage DS.

J Sep Sci. 2009 May;32(10):1632-41. doi: 10.1002/jssc.200900074.

30.

Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.

Schiel JE, Ohnmacht CM, Hage DS.

Anal Chem. 2009 Jun 1;81(11):4320-33. doi: 10.1021/ac9000404.

31.

Kinetic studies of biological interactions by affinity chromatography.

Schiel JE, Hage DS.

J Sep Sci. 2009 May;32(10):1507-22. doi: 10.1002/jssc.200800685. Review.

32.

Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Hage DS, Jackson A, Sobansky MR, Schiel JE, Yoo MJ, Joseph KS.

J Sep Sci. 2009 Mar;32(5-6):835-53. doi: 10.1002/jssc.200800640. Review.

33.

Density measurements of potassium phosphate buffer from 4 to 45 degrees C.

Schiel JE, Hage DS.

Talanta. 2005 Jan 30;65(2):495-500. doi: 10.1016/j.talanta.2004.06.029.

PMID:
18969825
34.

Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.

Joseph KS, Moser AC, Basiaga SB, Schiel JE, Hage DS.

J Chromatogr A. 2009 Apr 17;1216(16):3492-500. doi: 10.1016/j.chroma.2008.09.080. Epub 2008 Oct 1.

35.

Analysis of free drug fractions using near-infrared fluorescent labels and an ultrafast immunoextraction/displacement assay.

Ohnmacht CM, Schiel JE, Hage DS.

Anal Chem. 2006 Nov 1;78(21):7547-56. Erratum in: Anal Chem. 2007 Jan 1;79(1):385.

36.

Applications of silica supports in affinity chromatography.

Schiel JE, Mallik R, Soman S, Joseph KS, Hage DS.

J Sep Sci. 2006 Apr;29(6):719-37. Review.

PMID:
16830485
37.
38.

[Consideration of assistants' performance].

Schiel J.

Zahnarztl Mitt. 1989 Jun 16;79(12):1422-3. German. No abstract available.

PMID:
2800739
39.

Life experience patterns and development of college leadership roles.

Boardman WK, Calhoun LG, Schiel JH Jr.

Psychol Rep. 1972 Aug;31(1):333-4. No abstract available.

PMID:
5055913

Supplemental Content

Loading ...
Support Center